Annual Cash & Cash Equivalents
$93.45 M
+$59.38 M+174.31%
December 31, 2023
Summary
- As of February 7, 2025, ACIU annual cash & cash equivalents is $93.45 million, with the most recent change of +$59.38 million (+174.31%) on December 31, 2023.
- During the last 3 years, ACIU annual cash & cash equivalents has fallen by -$90.70 million (-49.25%).
- ACIU annual cash & cash equivalents is now -53.23% below its all-time high of $199.80 million, reached on December 31, 2019.
Performance
ACIU Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$38.53 M
-$18.83 M-32.82%
September 30, 2024
Summary
- As of February 7, 2025, ACIU quarterly cash and cash equivalents is $38.53 million, with the most recent change of -$18.83 million (-32.82%) on September 30, 2024.
- Over the past year, ACIU quarterly cash and cash equivalents has dropped by -$24.65 million (-39.01%).
- ACIU quarterly cash and cash equivalents is now -82.73% below its all-time high of $223.09 million, reached on March 31, 2019.
Performance
ACIU Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ACIU Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +174.3% | -39.0% |
| 3 y3 years | -49.3% | -15.6% |
| 5 y5 years | -41.2% | -82.0% |
ACIU Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +174.3% | -58.8% | +13.1% |
| 5 y | 5-year | -53.2% | +174.3% | -80.7% | +13.1% |
| alltime | all time | -53.2% | +2695.1% | -82.7% | +13.1% |
AC Immune SA Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $38.53 M(-32.8%) |
| Jun 2024 | - | $57.36 M(-9.2%) |
| Mar 2024 | - | $63.18 M(-32.4%) |
| Dec 2023 | $93.45 M(+174.3%) | $93.45 M(+167.8%) |
| Sep 2023 | - | $34.90 M(-21.6%) |
| Jun 2023 | - | $44.49 M(-29.2%) |
| Mar 2023 | - | $62.87 M(+84.6%) |
| Dec 2022 | $34.07 M(-62.1%) | $34.07 M(-25.3%) |
| Sep 2022 | - | $45.64 M(-31.0%) |
| Jun 2022 | - | $66.17 M(+5.6%) |
| Mar 2022 | - | $62.64 M(-30.4%) |
| Dec 2021 | $89.94 M(-51.2%) | $89.94 M(-10.2%) |
| Sep 2021 | - | $100.15 M(-11.4%) |
| Jun 2021 | - | $113.07 M(-29.5%) |
| Mar 2021 | - | $160.40 M(-12.9%) |
| Dec 2020 | $184.16 M | $184.16 M(-4.1%) |
| Sep 2020 | - | $192.01 M(+2.9%) |
| Jun 2020 | - | $186.59 M(-2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $190.47 M(-4.7%) |
| Dec 2019 | $199.80 M(+25.7%) | $199.80 M(-6.8%) |
| Sep 2019 | - | $214.33 M(+1.8%) |
| Jun 2019 | - | $210.61 M(-5.6%) |
| Mar 2019 | - | $223.09 M(+40.4%) |
| Dec 2018 | $158.92 M(+24.5%) | $158.92 M(-21.7%) |
| Sep 2018 | - | $202.91 M(+97.2%) |
| Jun 2018 | - | $102.90 M(-10.5%) |
| Mar 2018 | - | $115.01 M(-9.9%) |
| Dec 2017 | $127.69 M(-14.6%) | $127.69 M(+5.8%) |
| Sep 2017 | - | $120.74 M(-7.1%) |
| Jun 2017 | - | $129.95 M(-5.8%) |
| Mar 2017 | - | $138.01 M(-7.7%) |
| Dec 2016 | $149.58 M(+93.2%) | $149.58 M(-8.3%) |
| Sep 2016 | - | $163.09 M(+94.0%) |
| Jun 2016 | - | $84.08 M(+19.6%) |
| Mar 2016 | - | $70.32 M(-9.2%) |
| Dec 2015 | $77.42 M(+2215.5%) | $77.42 M |
| Dec 2014 | $3.34 M | - |
FAQ
- What is AC Immune SA annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AC Immune SA?
- What is AC Immune SA annual cash & cash equivalents year-on-year change?
- What is AC Immune SA quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for AC Immune SA?
- What is AC Immune SA quarterly cash and cash equivalents year-on-year change?
What is AC Immune SA annual cash & cash equivalents?
The current annual cash & cash equivalents of ACIU is $93.45 M
What is the all time high annual cash & cash equivalents for AC Immune SA?
AC Immune SA all-time high annual cash & cash equivalents is $199.80 M
What is AC Immune SA annual cash & cash equivalents year-on-year change?
Over the past year, ACIU annual cash & cash equivalents has changed by +$59.38 M (+174.31%)
What is AC Immune SA quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ACIU is $38.53 M
What is the all time high quarterly cash and cash equivalents for AC Immune SA?
AC Immune SA all-time high quarterly cash and cash equivalents is $223.09 M
What is AC Immune SA quarterly cash and cash equivalents year-on-year change?
Over the past year, ACIU quarterly cash and cash equivalents has changed by -$24.65 M (-39.01%)